Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Optimal Sequence of Intracranial Radiotherapy Compared to Systematic Tyrosine Kinase Inhibitors for Gene-driven Brain Metastases in Targeted Treatment Era

NCT04832672 is registered in ClinicalTrials.gov with Chinese Academy of Medical Sciences as lead sponsor.

NCT NCT04832672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04832672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Optimal Sequence of Intracranial Radiotherapy Compared to Systematic Tyrosine Kinase Inhibitors for Gene-driven Brain Metastases in Targeted Treatment Era
Lead sponsor
Chinese Academy of Medical Sciences
Phase
Observational
Overall status
Completed
Start date
October 1, 2010
Completion date
March 1, 2021
Enrollment
570 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

the optimal sequence of radiotherapy and systematic tyrosine kinase inhibitors in treating brain metastases